CIK 0001802665 · Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822279923
- Phone
- (484) 539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-05 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise · Stock Option 10b5-1 | −20,000 | 185,000 | ||
| 2025-11-21 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −3,427 | $35.00 | $120K | 0 |
| 2025-09-30 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise | +45,000 | 45,000 | ||
| 2025-09-30 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −24,039 | $27.56 | $663K | 20,961 |
| 2025-09-30 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −45,000 | 45,000 | ||
| 2025-08-28 | Valor IV Pharma Holdings, LLC 10% owner | Other disposition | −6,618,033 | 0 | ||
| 2025-08-15 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −21,573 | $36.50 | $787K | 0 |
| 2025-05-25 | Graf R. Mark Director | Grant or award · Stock Option | +14,522 | 14,522 | ||
| 2025-05-15 | Sabater Juan A. Director | Grant or award · Stock Option | +14,522 | 14,522 | ||
| 2025-05-15 | Gracias Antonio J. Director | Grant or award · Stock Option | +14,522 | 14,522 | ||
| 2025-05-15 | Philip Ron M Director | Grant or award · Stock Option | +14,522 | 14,522 | ||
| 2025-05-15 | Szyper Linda M Director | Grant or award · Stock Option | +14,522 | 14,522 | ||
| 2025-05-15 | Anastasiou Peter Director | Grant or award · Stock Option | +14,522 | 14,522 | ||
| 2025-05-15 | Sender Gary Director | Grant or award · Stock Option | +14,522 | 14,522 | ||
| 2025-05-01 | Budur Kumar CHIEF MEDICAL OFFICER | Option exercise | +18,750 | 18,750 | ||
| 2025-05-01 | Budur Kumar CHIEF MEDICAL OFFICER | Shares withheld for taxes | −8,869 | $29.86 | $265K | 9,881 |
| 2025-05-01 | Budur Kumar CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −18,750 | 18,750 | ||
| 2025-04-07 | Zaeske Adam H. CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2025-04-07 | Zaeske Adam H. CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +30,000 | 30,000 | ||
| 2025-04-02 | Philip Ron M Director | Grant or award · Stock Option | +14,077 | 14,077 |
Page 5 of 14 · 268 trades